#Linkdoc technology ltd registration#
#Linkdoc technology ltd Offline#

But Meihua has held up better, and its shares are down by a more modest 8% in the two months since their February trading debut. LianBio hasnвЂ™t done so well, with its shares down by more than 60% from its October listing price. Meantime, two companies вЂ“ drug developer LianBio ( LIAN) and disposable medical device seller Meihua International ( MHUA) defied the odds and managed to make U.S. But that decision was more likely prompted by ChinaвЂ™s separate crackdown on the private education sector that specifically targeted companies offering K-12 services. We havenвЂ™t heard anything from Soulgate since it scrapped its listing plan, though media have reported that Hello raised $280 million from private sources last November.ДЄnother company to formally withdraw its offering was high-tech education services company Spark Education. Other high-profile names that took similar action last year included online socializing app Soulgate and shared bike operator Hello, Inc. LinkDoc isnвЂ™t the only company to formally withdraw its U.S. IPO plans have gone silent will now formally abandon those plans.

That means itвЂ™s a relatively unusual case, and not necessarily indicative that other Chinese companies whose U.S. probably owes to two major factors: its urgent need of cash and also its realization that it might need to get a data security review before making such a listing. listing plan signals the company will soon file for such a Hong Kong IPO, probably within the next month. Our bets are that the formal withdrawal of the U.S. No reports of new private funding have emerged since then, though a Hong Kong media report last September cited unnamed sources saying the company was seeking to raise $300 million from private sources and was also studying a potential Hong Kong IPO. The abrupt halt to its IPO created questions about the companyвЂ™s future since it had previously said that even with the $200 million from the listing it would still only have enough cash to fund its operations for the next 12 months.

#Linkdoc technology ltd Offline#

Its main platform, called LinkCare, integrates online and offline channels to assist patients, especially those suffering from cancer, to better manage their illnesses in and out of hospital. But it abruptly scrapped the plan at the 11 th hour as ChinaвЂ™s cybersecurity regulator was targeting a growing number of companies for data security reviews.ДЇounded in 2014 and backed by e-commerce giant AlibabaвЂ™s ( BABA) healthcare arm, Alibaba Health Information Technology ( OTCPK:ALBHF) ( OTCPK:ALBBY) (0241.HK), LinkDoc garners and processes large volumes of medical data for conducting research on new drugs and patient care, with a special focus on cancer treatments. listings, seeking to raise around $200 million through its IPO. LinkDoc was one of a steady stream of money-losing but fast-growing tech companies to file for U.S.

Accordingly, it is increasingly making exceptions and allowing such companies to list, in its own bid to diversify beyond the types of real estate and manufacturing companies that were its traditional bread and butter.ДЄll that said, letвЂ™s return first to LinkDoc, including a review of the bumpy road that brings us to the present, before looking at some of the other listings also in limbo.

But Hong Kong has its own obstacles, most notably tough profitability requirements that would normally disqualify a money-losing company like LinkDoc.Д«ut the Hong Kong Stock Exchange has shown growing flexibility in the last few years to accommodate this kind of high-tech, high-growth company. IPO application means LinkDoc has begun the early confidential steps for a Hong Kong IPO that could soon lead to its first public filing. IPOs around the same time and have gone silent since then? At least one such plan appears to still be moving forward, which weвЂ™ll describe shortly.ДЄ potential alternative for LinkDoc and the others could be Hong Kong listings, and itвЂ™s quite possible the formal withdrawal of its U.S. listing now formally dead, the big questions are: What will LinkDoc do next, and whatвЂ™s ahead for the handful of other Chinese companies that had filed for U.S.

#Linkdoc technology ltd registration#

вЂњIn light of the current capital markets condition, the company is considering other alternatives and has determined not to proceed at this time with the offering and sale of the securities proposed to be covered by the registration statement,вЂќ LinkDoc said in a brief statement accompanying its withdrawal notice dated April 11. Readers might recall this company had the misfortune of trying to list at the height of a storm centered on the Uber-like DiDi Global ( DIDI ) over data security concerns from ChinaвЂ™s cybersecurity regulator. securities regulator last week it was withdrawing its IPO application first filed last June. Medical big data firm LinkDoc Technology Limited ( LDOC) has formally signaled the end of its hopes for a U.S.